Log In
Print
BCIQ
Print
Print this Print this
 

NOX-S93

  Manage Alerts
Collapse Summary General Information
Company Noxxon Pharma AG
DescriptionSphingosine 1-phosphate (S1P) inhibitor
Molecular Target Sphingosine 1-phosphate (S1P)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Aptamer
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today